[Issuer Free Writing Prospectus dated June 27, 2014 Relating to Preliminary Prospectus Supplements dated June 17, 2014 (as supplemented by Issuer Free Writing Prospectus dated June 23, 2014) to Prospectuses dated December 16, 2010, July 23, 2012 and June 17, 2014 Registration Nos. 333-171069 333-182624 and 333-196591 . Unless the context requires otherwise, the words “we,” “our,” and “us” refer]
[CHINA BIOLOGIC PRODUCTS, INC. UNDERWRITING AGREEMENT June 27, 2014 June 27, 2014 Morgan Stanley & Co. International plc for the Underwriters named in Schedule II hereto Ladies and Gentlemen: Company Underwriters Manager Selling Stockholder Firm Shares Company Additional Shares Selling Stockholder Additional Shares Additional Shares Shares. Common Stock Sellers China Biologic Products, Inc., a Delaware corporation (the “ Commission Shelf] [China Biologic Announces Pricing of Public Offering of Common Stock BEIJING, China – June 27, 2014 The Company intends to use the proceeds from the offering primarily for general corporate purposes. In addition, if appropriate opportunities arise in the future to acquire or invest in complementary businesses, products or technologies, the Company may use a portion of the net proceeds] []
[Issuer Free Writing Prospectus dated June 23, 2014 Relating to Preliminary Prospectus Supplement dated June 17, 2014 to Prospectuses dated December 16, 2010, July 23, 2012 and June 17, 2014 Registration Nos. 333-171069 333-182624 and 333-196591 The following information supplements and updates the information contained in the Company’s preliminary prospectus supplement dated June 23, 2014. All references to page numbers]
[Issuer Free Writing Prospectus dated June 23, 2014 Relating to Preliminary Prospectus Supplement dated June 17, 2014 to Prospectuses dated December 16, 2010, July 23, 2012 and June 17, 2014 Registration Nos. 333-171069 333-182624 and 333-196591 The following information supplements and updates the information contained in the Company’s preliminary prospectus supplement dated June 23, 2014. All references to page numbers]
[China Biologic Announces Favorable Reduction in Value Added Tax Rate BEIJING, China – June 23, 2014 About China Biologic China Biologic is a leading plasma-based biopharmaceutical company in China. The Company’s products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and] []
[China Biologic Announces Favorable Reduction in Value Added Tax Rate BEIJING, China – June 23, 2014 About China Biologic China Biologic is a leading plasma-based biopharmaceutical company in China. The Company’s products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and] []
[PROSPECTUS SUPPLEMENT Page About This Prospectus Supplement S-1 Prospectus Supplement Summary S-2 Risk Factors S-8]
[PROSPECTUS SUPPLEMENT Page About This Prospectus Supplement S-1 Prospectus Supplement Summary S-2 Risk Factors S-8]
